期刊文献+

增生过长子宫内膜和内膜腺癌雌激素、孕酮受体的检测 被引量:2

Assay of estrogen and progesterone receptors in endometrial hyperplasia and adenocarcinoma of endometrium
下载PDF
导出
摘要 应用酶联亲和组化法检测97例增生期、分泌期、腺瘤型增生过长子宫内膜及内膜腺癌的雌激素受体(ER)和孕酮受体(PR),并应用微波技术与常规组化染色相比较。结果经统计学处理:子宫内膜腺癌的ER、PR阳性率高于非肿瘤性子宫内膜(P<0.05),其与癌组织分化程度有关,但与肌层浸润深浅及绝经情况无关;增生期与分泌期宫内膜受体差异有显著性(P<0.05),但与增生过长子宫内膜受体阳性率无显著性差异(P>0.05)。提示:①ER、PR的检测为研究子宫内膜癌的发生及临床内分泌治疗提供理论依据;②微波技术是一项快速、灵敏的新方法,值得进一步推广应用。 In this study,the determination of estrogen receptor(ER)and progesterone receptor(PR) was performed on the endometrium at the proliferative and secretory stages,adenomatous hyperplasia of endometrium,and adenocarcinoma of endometrium of 97 specimens with the enzyme-linked affinity histochemistry method.And by using the technique of microwave, this was compared with regular histochemical staining. Through statistical treatment,the results showed that the positive rates of ER and PR in adenocacinoma of endometrium were significantly higher than those in the non-neoplastic endometrium (P<0. 05).They were related to the tumor differentiation, but there were no significant statistical differences in the degree of muscle infiltration and menopausal status, There were significant differences between the receptors on endometrium at the proliferative and secretory stages(P<0.05),but no significant differences in adenomatous hyperplasia of endometrium(P> 0.05). The results suggested that the discovery of ER and PR might provide theoretical basis for the genesis of adenocarcinoma and the clinical endocrine therapy.The data suggested that microwave technique might be a fast,sensitive and new method.Further popularization is needed.
出处 《河南医科大学学报》 1995年第3期252-256,共5页 Journal of Henan Medical University
关键词 子宫内膜 雌激素 孕激素 受体 免疫组织化学 endometrium adenocarcinoma of endometrium estrogen receptor progesterone receptor analysis
  • 相关文献

参考文献1

  • 1刘尚廉,沈镇宙,唐锦霞,张廷璆,韩企夏,施达仁,姚连生.乳腺癌雌激素受体的酶联雌二醇组化标记法[J]肿瘤,1986(03).

同被引文献7

  • 1Mutch DG,Soper JT,Budwit-Novotny DA,et al.Endometrial adenocarcinoma estrogen receptor contene:association of clinicopathogic features with immunohistochemical analysis compared with standred biochemical methods.Am J Obstet Gynecol,1987;121(9):924.
  • 2Kurman RJ,Kaminski PF,Norris HJ,The behavior of endometrial hyperplasia.A long-term study of untreated byperplasia in 170 patients.Cancer,1985;56:403.
  • 3Ferency A,Bertrand G,Gelfand MM,Proliferation kinetics of human endometrium during the normal menstrual cycle.Am J Obstet Gynecol,1979;133(8):859.
  • 4Ciocca DR,Puy LA.Fasoli LC,Study of estrogen receptor,progestrone receptor,and the estrogen-regulated Mr 24 000 protien in patients with carcinomas of the endomentrium and cervix.Cancer Res,1989;49:4298-4304.
  • 5Budwit-Novtny DA,McCarty KS,Cox EB,et al.Immunobistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody.Cancer Res,1986;46(10):5419.
  • 6Brandon DD,Bcthea CL.Strawn EY,et al.Progesterone receptor messenger ribonuclonal acid and protein are overexpressed in human uterine leiomyoma.Am J OBbstet Gynecol,1993;169:78-85.
  • 7Aronica SM,Katzenellenbogen BS.Progestrone receptor regulation in uterine cell:stimulation by estrogen,cyclic adenosine 3,5'-monophosphate:and insulin-like growth factor-1 and suppresion by antiestrogene and protein kinase inhibitors.Endocrinology,1991;128:2045-2052.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部